Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06578234
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-15
Brief Title:
Hyperemic mYocardial Perfusion by adEnosine at diffeRent Doses
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Hyperemic mYocardial Perfusion by adEnosine at diffeRent Doses
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HYPER
Brief Summary:
Adenosine is a commonly used pharmaceutical stressor at cardiac magnetic resonance examinations to assess suspected chronic coronary syndrome CCS However several studies have reported that the current use of adenosine does not induce adequate hyperemic response in a substantial number of patients leading to false diagnostics The aim of this trial is to investigate the hyperemic effect of the standard dose of adenosine 140 microgramkgmin to the high dose of adenosine 210 microgramkgmin to improve the diagnostic methods using adenosine as a stressor and ultimately improve treatment decisions and patient prognosis in CCS
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None